Concurrently, S&P revised SRMC’s outlook to negative from stable.
“The outlook revision reflects our view of SRMC’s declining market share and weakened operations, which followed the significant impact from Hurricane Matthew in October 2016,” said S&P credit analyst Kelsey Thomas.
In addition, the outlook revision is supported by the health system’s decreasing financial flexibility as a result of a $42 million bond to fund capital projects.
More articles on healthcare finance:
Allegheny Health Network posts slim profit in Q1: 5 things to know
Consumerism and the patient payment transition: 2 experts discuss
Mississippi hospital changes ER pricing policy after newspaper’s probe into child’s expensive visit
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
